RCMU
GMAB icon

Rokos Capital Management (UK)’s Genmab GMAB Stock Holding History

Rokos Capital Management (UK)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,447
Closed -$889K – 68
2022
Q3 		$889K Hold
27,447
– – 0.03% 70
2022
Q2 		$886K Sell
27,447
-1,118
-4% -$36.2K 0.03% 69
2022
Q1 		$10.5M Buy
+28,565
New +$980K 0.49% 33

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rokos Capital Management (UK)'s GMAB Position: Q4 2022 in Review

Rokos Capital Management (UK) sold out of Genmab (GMAB) in Q4 2022, closing a stake of 27,447 shares — an estimated $889K sold.

Rokos Capital Management (UK) first reported a position in GMAB in Q1 2022 and held it in 3 quarters. The position peaked at $10.5M in Q1 2022. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

  • Rokos Capital Management (UK) reported no remaining Genmab position as of Q4 2022 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 27,447 Genmab shares in Q4 2022, an estimated $889K.
  • Rokos Capital Management (UK) first reported a position in Genmab in Q1 2022 and held it in 3 quarters.
  • Rokos Capital Management (UK)'s Genmab position peaked at $10.5M in Q1 2022.
  • 237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2022, filed 14 Feb 2023.